肝病学
脂肪肝
医学
临床实习
内科学
疾病
代谢综合征
肝病
重症监护医学
生物信息学
家庭医学
生物
肥胖
作者
Yiwen Shi,Qian Xiao,Jian‐Gao Fan
标识
DOI:10.3760/cma.j.cn51113-20201102-00592
摘要
Recently, metabolic-associated fatty liver has become the world's highest prevalence of chronic liver disease. Moreover, it is closely related to metabolic syndrome and related diseases, bringing a huge burden. Previously, the global expert consensus on renaming for non-alcoholic fatty liver and the diagnostic criteria for metabolic-associated fatty liver has increased the certainty of further clinical research and practice. Presently, the research on metabolic-associated fatty liver is progressing rapidly, and the opinions and data based on clinical evidence are constantly updated. Hepatology international has published the Asian Pacific Association for the Study of liver diseases' clinical guidelines on the management of metabolic-associated fatty liver disease , which aims to promote clinical practice and improve the efficiency of clinical research. Here, we have translated the published recommendations into Chinese language, hoping to help most health professionals make clinical decisions.
科研通智能强力驱动
Strongly Powered by AbleSci AI